CSS
AXSM icon

Cubist Systematic Strategies’s Axsome Therapeutics AXSM Stock Holding History

Cubist Systematic Strategies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.57M Sell
21,165
-138,068
-87% -$15.6M 0.01% 1407
2025
Q2 		$16.6M Sell
159,233
-18,581
-10% -$1.97M 0.08% 365
2025
Q1 		$20.7M Buy
177,814
+60,877
+52% +$6.94M 0.13% 186
2024
Q4 		$9.89M Buy
+116,937
New +$10.8M 0.06% 475
2024
Q2 		– Sell
-60
Closed -$4.79K – 2981
2024
Q1 		$4.79K Buy
+60
New +$5.04K ﹤0.01% 3545
2023
Q1 		– Sell
-9,199
Closed -$604K – 3901
2022
Q4 		$710K Sell
9,199
-66,634
-88% -$3.98M ﹤0.01% 2743
2022
Q3 		$3.38M Buy
75,833
+42,465
+127% +$2.12M 0.02% 1455
2022
Q2 		$1.28M Buy
33,368
+14,902
+81% +$471K 0.01% 2262
2022
Q1 		$764K Sell
18,466
-9,725
-34% -$301K 0.01% 2245
2021
Q4 		$1.06M Sell
28,191
-19,093
-40% -$703K 0.01% 1863
2021
Q3 		$1.56M Buy
+47,284
New +$1.84M 0.02% 1207
2021
Q2 		– Sell
-16,823
Closed -$953K – 2917
2021
Q1 		$953K Buy
16,823
+14,413
+598% +$1.01M 0.01% 1570
2020
Q4 		$196K Buy
2,410
+306
+15% +$22.9K ﹤0.01% 2244
2020
Q3 		$150K Sell
2,104
-3,241
-61% -$253K ﹤0.01% 2204
2020
Q2 		$440K Buy
5,345
+2,237
+72% +$172K 0.01% 1647
2020
Q1 		$183K Sell
3,108
-16,578
-84% -$1.35M ﹤0.01% 1768
2019
Q4 		$2.04M Buy
19,686
+15,260
+345% +$616K 0.04% 740
2019
Q3 		$90K Sell
4,426
-11,083
-71% -$285K ﹤0.01% 1956
2019
Q2 		$399K Buy
+15,509
New +$311K 0.01% 1624

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cubist Systematic Strategies's AXSM Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Axsome Therapeutics (AXSM) stake by 87% in Q3 2025, selling an estimated $15.6M and leaving 21,165 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #1407.

Cubist Systematic Strategies first reported a position in AXSM in Q2 2019 and has held it in 19 quarters since. The position peaked at $20.7M in Q1 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Cubist Systematic Strategies held 21,165 shares of Axsome Therapeutics worth $2.57M as of Q3 2025.
  • Cubist Systematic Strategies sold 138,068 Axsome Therapeutics shares in Q3 2025, an estimated $15.6M.
  • Axsome Therapeutics made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1407 holding.
  • Cubist Systematic Strategies first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • Cubist Systematic Strategies's Axsome Therapeutics position peaked at $20.7M in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.